SCHORNO DEAN L (EVP &Chief Financial Officer) sold 6.2% of their position (3.77K shares) of RIGEL PHARMACEUTICALS INC on the open market
Open‑market sale worth $80.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/6/2025ACC: 0000905148-25-000413
Officer· EVP &Chief Financial Officer
Since Jan 2019
-3.77K
Net shares
Net seller
$80.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
3.77K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.04K
Price / share
$20.92
Trade value
$42.60K
% of position
3.3%
2/4/2025
61.01K→58.97K
Common Stock
Direct
Shares
−1.73K
Price / share
$21.93
Trade value
$38.02K
% of position
2.9%
2/5/2025
58.97K→57.23K
Total
Net shares
−3.77K
Net value
-$80.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | S · Sale | −2.04K | $20.92 | $42.60K | 3.3% | 61.01K | 58.97K |
| Common Stock Direct | 2/5/2025 | S · Sale | −1.73K | $21.93 | $38.02K | 2.9% | 58.97K | 57.23K |
| Total | −3.77K | -$80.61K | ||||||
Derivative Transactions0
No derivative transactions reported